Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Neoleukin Therapeutics
(NLTX) Q1 2023
Earnings
NLTX
May 8
Confirmed
Aug 2022
Nov 2022
Q4 2022
Q1 2023
-0.3
-0.24
-0.18
-0.12
Details
Expected EPS
-0.12
Actual EPS
-0.2
Surprise EPS
-0.08
Surprise Percent
-66.67%
Description
Neoleukin Therapeutics (NLTX) has reported earnings of -0.2 per share for Q1 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login